绝经后妇女非酒精性脂肪性肝病及其相关合并症的运动干预处方

Exercise intervention prescription for postmenopausal women with nonalcoholic fatty liver disease and related comorbidities

绝经后妇女非酒精性脂肪性肝病(NAFLD)患病率显著高于绝经前妇女,甚至超过了同期男性患病率,运动干预仍是预防与治疗绝经后妇女NAFLD的有效方法。同时,该年龄段NAFLD患病妇女常合并肌少症、骨质疏松、心血管疾病以及糖尿病等慢性疾病,这要求相应运动处方应更具针对性,同时对可能的合并症进行前瞻性干预。本文在总结相关文献的基础上,对绝经后妇女NAFLD以及相关合并症的运动干预处方提出针对性建议。

The prevalence rate of nonalcoholic fatty liver disease(NAFLD)in postmenopausal women is significantly higher than that in premenopausal women and even exceeds that in men of the same age group,and exercise intervention remains an effective method for the prevention and treatment of NAFLD in postmenopausal women.In addition,postmenopausal women with NAFLD often have comorbidities such as sarcopenia,osteoporosis,cardiovascular diseases,and diabetes,which requires targeted exercise prescriptions and proactive intervention for potential comorbidities.Through a literature review,this article provides targeted recommendations for exercise intervention prescriptions in postmenopausal women with NAFLD and related comorbidities.